The Czech Republic currently reports a research & development by government, health & medical sciences in constant ppp $ of 2,496.88 million, a decrease of 284.53 million (-10.2%) from 2022.
Research & development by government, health & medical sciences in constant PPP $ in the Czech Republic
No matching regions
More indicators for the Czech Republic
Business R&D services in local currency
41,247.51M
+4,559.53M
(2022)
R&D financed by rest of the world in local currency
415,913.40M
+43,474.09M
(2022)
Government R&D financed by rest of the world in local currency
40,048.76M
+2,660.91M
(2022)
Business R&D financed by rest of the world in local currency
334,813.62M
+39,228.60M
(2022)
Non-profit R&D growth rate
32.43%
+38.54%
(2022)
Czech Republic Government R&D in health & medical sciences in constant PPP $ between 2000 and 2023
| Period | Value | Change |
|---|---|---|
| 2023 | 2,496.88M | -284.53M |
| 2022 | 2,781.41M | -195.29M |
| 2021 | 2,976.70M | -78.88M |
| 2020 | 3,055.58M | -23.65M |
| 2019 | 3,079.23M | -24.04M |
| 2018 | 3,103.27M | +167.89M |
| 2017 | 2,935.38M | +293.40M |
| 2016 | 2,641.98M | +123.74M |
| 2015 | 2,518.24M | -64.64M |
| 2014 | 2,582.88M | -5.35M |
| 2013 | 2,588.23M | +6.35M |
| 2012 | 2,581.88M | -499.03M |
| 2011 | 3,080.91M | +411.21M |
| 2010 | 2,669.70M | -169.81M |
| 2009 | 2,839.51M | +528.58M |
| 2008 | 2,310.93M | -245.19M |
| 2007 | 2,556.12M | +236.90M |
| 2006 | 2,319.22M | +228.26M |
| 2005 | 2,090.96M | +1,166.35M |
| 2004 | 924.61M | -33.25M |
| 2003 | 957.86M | -9.54M |
| 2002 | 967.40M | -20.46M |
| 2001 | 987.86M | +95.48M |
| 2000 | 892.37M |